Duaklir Genuair (aclidinium bromide/formoterol fumarate dihydrate)

pCPA File Number: 20859

Negotiation Status:

Concluded with an LOI

Indication(s):

Chronic Obstructive Pulmonary Disease (COPD)

Sponsor/Manufacturer:

AstraZeneca Canada Inc.

CDA-AMC Project Number:

SR0423-000

pCPA Engagement Letter Issued:

2015-10-23

Negotiation Process Concluded:

2015-12-15